FAKTOR-ZERTIFIKAT - TANDEM DIABETES CARE Share Price

Certificat

DE000JK78CT7

Real-time Bid/Ask 13:05:07 27/06/2024 BST
1.3 EUR / 1.6 EUR +9.02% Intraday chart for FAKTOR-ZERTIFIKAT - TANDEM DIABETES CARE
Current month-96.86%
1 month-95.66%
Date Price Change
27/06/24 1.31 -1.50%
26/06/24 1.33 +13.68%
25/06/24 1.17 -61.00%
24/06/24 3 +2.39%
21/06/24 2.93 +1.03%

Delayed Quote Börse Stuttgart

Last update June 27, 2024 at 10:01 am

More quotes

Static data

Product typeProduits Exotiques
Buy / SellCALL
Underlying TANDEM DIABETES CARE, INC.
Issuer J.P. Morgan
WKN JK78CT
ISINDE000JK78CT7
Date issued 06/05/2024
Strike 36.14 $
Maturity Unlimited
Parity 3.71 : 1
Emission price 10.14
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 42.53
Lowest since issue 1.14
Spread 0.2
Spread %13.33%

Company Profile

Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.
Sector
-
More about the company

Ratings for Tandem Diabetes Care, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Tandem Diabetes Care, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
40.64 USD
Average target price
49.93 USD
Spread / Average Target
+22.87%
Consensus